These safety characterisation studies have established the pre-clinical basis for the well-tolerated profile of both peptides in rodent research models and havent identified significant toxicological findings at doses producing meaningful biological effects and contributing to their establishment as reference research compounds in pre-clinical regenerative biology
It does not establish an authorised indication, effective dose, long-term safety profile or meaningful patient benefit
In contrast, GHK-Cu administered subcutaneously is released into the bloodstream instantly and in a controlled dose, which triggers more than 300 repair-related genes, helps to multiply fibroblast growth and contributes to the longevity of epidermal stem cells located in the basal layer
Increases energy, supports fat loss, and enhances mitochondrial efficiency
Any problem solved quickly
doi: 10.18203/2320-6012.ijrms20191496 20